SciClone Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 49   

Articles published

SCLN 6.98 -0.11 (-1.55%)
price chart
SciClone Pharmaceuticals Inc. (SCLN) Jumps 8.83% on August 25
SciClone Pharmaceuticals Inc. (SCLN) was among the biggest gainers on the Russell 2000 for August 25 as the stock popped 8.83% to $6.90, representing a gain of $0.56 per share.
Related articles »  
SciClone Pharmaceuticals (SCLN) Gains; DC Bead Approved by China FDA
SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN), and its partner BTG plc today announced that the China Food and Drug Administration has approved the registration of DC Bead for the embolization of malignant hypervascularized tumors.
SciClone Pharma, BTG Say China's FDA Approves DC Bead  RTT News
Related articles »  
Stocks Watch List � SciClone Pharmaceuticals, (NASDAQ:SCLN), Rex Energy ...
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)started its trading session with the price of $7.35 and closed at $7.18 by scoring -2.84%.
Related articles »  
SciClone Pharmaceuticals Inc. (SCLN) Releases FY14 Earnings Guidance
SciClone Pharmaceuticals logo SciClone Pharmaceuticals Inc. (NASDAQ:SCLN) issued an update on its FY14 earnings guidance on Monday morning.
Related articles »  
Aegis Reiterates "Buy" Rating for SciClone Pharmaceuticals (SCLN)
SciClone Pharmaceuticals Inc. logo SciClone Pharmaceuticals (NASDAQ:SCLN)'s stock had its �buy� rating reaffirmed by investment analysts at Aegis in a note issued to investors on Friday.
SciClone Pharmaceuticals's "Buy" Rating Reiterated at Aegis (SCLN)  Mideast Time
Related articles »  
Stocks in the Spotlight: SciClone Pharmaceuticals, Inc. (SCLN), Synta ...
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) closed latest trading day at $6.90, down -1.00%, on volume of over 1.03 shares.
SciClone Pharmaceuticals Hits New 52-Week High at $7.24 (SCLN)  Intercooler
Related articles »  
SciClone Pharmaceuticals CFO Sells $254182 in Stock (SCLN)
SciClone Pharmaceuticals has a 52-week low of $4.24 and a 52-week high of $7.25. The stock's 50-day moving average is $5.70 and its 200-day moving average is $5.05.
SciClone Pharmaceuticals Trading Down 3.2% Following Insider Selling (SCLN)  Watch List News (press release)
Related articles »  
Stocks to Keep Your Eyes on: SciClone Pharmaceuticals, Inc. (SCLN), OraSure ...
SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN) augmented +8.83% to close at $6.90 in the last trading session and its total traded volume was 852,981 shares versus average volume of 274,367.
Aegis Reaffirms Buy Rating for SciClone Pharmaceuticals (SCLN)
SciClone Pharmaceuticals Inc. logo SciClone Pharmaceuticals (NASDAQ:SCLN)'s stock had its �buy� rating reissued by investment analysts at Aegis in a note issued to investors on Friday.
SciClone Pharmaceuticals Director Nancy T. Chang Acquires 25040 Shares ...
SciClone Pharmaceuticals (NASDAQ:SCLN) last issued its quarterly earnings data on Monday, August 11th. The company reported $0.20 earnings per share for the quarter, beating the analysts' consensus estimate of $0.10 by $0.10.
Insider Buying: SciClone Pharmaceuticals Director Buys 25040 Shares of Stock ...  sleekmoney
Insider Buying: SciClone Pharmaceuticals Director Purchases 25040 Shares of ...  Ticker Report
Related articles »